Novel Immunotherapeutics Stocks in the News (Nasdaq:AEMD), (Nasdaq:HURA) (NYSE: AZN) (Nasdaq: ELTX)

(Investorideas.com Newswire) a go-to investing platform, releases an industry snapshot looking at advancements in novel immunotherapeutics, featuring Aethlon Medical, Inc.(Nasdaq:AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device for oncology and other indications Novel immunotherapeutics have transformed oncology, moving away from broad, non-specific treatments toward highly personalized strategies that harness the patient's immune ...